Daito Pharmaceutical Co.,Ltd. (TYO:4577)
Japan
· Delayed Price · Currency is JPY 1,260.00
-5.00 (-0.40%)
Apr 28, 2026, 3:30 PM JST
Daito Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '26 Feb 28, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 | 2020 - 2016 |
| Net Income | - | 2,958 | 4,218 | 5,076 | 6,720 | 5,873 | Upgrade
|
| Depreciation & Amortization | - | 4,332 | 3,659 | 3,870 | 3,313 | 3,154 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 384 | 165 | 17 | 56 | 315 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -409 | -326 | 87 | -47 | -1 | Upgrade
|
| Loss (Gain) on Equity Investments | - | -75 | - | - | - | - | Upgrade
|
| Other Operating Activities | - | -571 | -1,111 | -2,405 | -1,820 | -1,955 | Upgrade
|
| Change in Accounts Receivable | - | -4,891 | 2,221 | -1,502 | -3,299 | 2,723 | Upgrade
|
| Change in Inventory | - | 2,419 | -2,640 | -1,413 | -1,041 | -3,609 | Upgrade
|
| Change in Accounts Payable | - | -360 | 802 | 538 | 22 | -765 | Upgrade
|
| Change in Other Net Operating Assets | - | 2,110 | -1,806 | -113 | 466 | -553 | Upgrade
|
| Operating Cash Flow | - | 5,897 | 5,182 | 4,155 | 4,370 | 5,182 | Upgrade
|
| Operating Cash Flow Growth | - | 13.80% | 24.72% | -4.92% | -15.67% | 20.34% | Upgrade
|
| Capital Expenditures | - | -6,789 | -6,220 | -5,505 | -4,627 | -6,318 | Upgrade
|
| Sale of Property, Plant & Equipment | - | -65 | - | - | - | - | Upgrade
|
| Cash Acquisitions | - | -707 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -241 | -56 | -51 | -106 | -31 | Upgrade
|
| Investment in Securities | - | 438 | 335 | - | 256 | 5 | Upgrade
|
| Other Investing Activities | - | -1 | 11 | -10 | 77 | 20 | Upgrade
|
| Investing Cash Flow | - | -7,365 | -5,930 | -5,566 | -4,400 | -6,324 | Upgrade
|
| Long-Term Debt Issued | - | 6,000 | 4,000 | 3,000 | 1,500 | 2,000 | Upgrade
|
| Total Debt Issued | - | 6,000 | 4,000 | 3,000 | 1,500 | 2,000 | Upgrade
|
| Long-Term Debt Repaid | - | -3,099 | -2,029 | -1,638 | -1,444 | -1,713 | Upgrade
|
| Total Debt Repaid | - | -3,099 | -2,029 | -1,638 | -1,444 | -1,713 | Upgrade
|
| Net Debt Issued (Repaid) | - | 2,901 | 1,971 | 1,362 | 56 | 287 | Upgrade
|
| Issuance of Common Stock | - | - | - | 302 | 1,527 | 1,798 | Upgrade
|
| Repurchase of Common Stock | - | -623 | -1,176 | -110 | - | - | Upgrade
|
| Common Dividends Paid | - | -998 | -907 | -931 | -660 | -658 | Upgrade
|
| Other Financing Activities | - | -278 | -71 | -7 | 66 | -3 | Upgrade
|
| Financing Cash Flow | - | 1,002 | -183 | 616 | 989 | 1,424 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -54 | 51 | 20 | 48 | 5 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| Net Cash Flow | - | -519 | -879 | -774 | 1,008 | 288 | Upgrade
|
| Free Cash Flow | - | -892 | -1,038 | -1,350 | -257 | -1,136 | Upgrade
|
| Free Cash Flow Margin | - | -1.76% | -2.21% | -2.99% | -0.59% | -2.33% | Upgrade
|
| Free Cash Flow Per Share | - | -29.32 | -33.08 | -42.65 | -8.39 | -37.82 | Upgrade
|
| Cash Interest Paid | - | 126 | 40 | 13 | 9 | 7 | Upgrade
|
| Cash Income Tax Paid | - | 842 | 1,265 | 2,411 | 1,924 | 2,088 | Upgrade
|
| Levered Free Cash Flow | - | -4,444 | 330.13 | -918 | -406.63 | -2,781 | Upgrade
|
| Unlevered Free Cash Flow | - | -4,367 | 355.75 | -910.5 | -401 | -2,776 | Upgrade
|
| Change in Working Capital | - | -722 | -1,423 | -2,490 | -3,852 | -2,204 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.